Showing results (131-140 of 148) with videos related to
Sort By:
Pageof 15
Blood|April 20, 2021
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemiaDanika Di Giacomo, Roberta La Starza, Paolo Gorello, et al.The Journal of Experimental Medicine|August 20, 2021
Single-cell imaging of T cell immunotherapy responses in vivoChuan Yan, Qiqi Yang, Songfa Zhang, et al.Leukemia|May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.Nature Communications|June 3, 2026
MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcomaYun Wei, Luis Antonio Corchete Sánchez, Sabateeshan Mathavarajah, et al.Blood|May 11, 2022
Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemiaSaara Laukkanen, Alexandra Veloso, Chuan Yan, et al.Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.The New England Journal of Medicine|March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeJan Cools, Daniel J DeAngelo, Jason Gotlib, et al.Cancer Cell|June 14, 2011
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.Haematologica|December 7, 2023
CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemiaBruno A Cardoso, Mafalda Duque, Ana Gírio, et al.Nature Genetics|December 25, 2012
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Zeynep Kalender Atak, Ning Li, et al.Pageof 15